Related Experiment Video
Updated: Jul 16, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Liver dysfunction in patients with acute pulmonary embolism
Sahin Aslan1, Mehmet Meral, Metin Akgun
1Department of Emergency Medicine, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Aim:
Although liver injury due to cardiac, chronic respiratory and circulatory failure has been reported, this has yet to be studied in patients with pulmonary embolism (PE). We investigated liver injury in patients with acute PE.
Methods:
We retrospectively reviewed 107 acute PE patients over a two-year period. Patients were categorized as having: (1) severe (P(a)O(2) < 45 mmHg), moderate (45 mmHg = P(a)O(2)= 60 mmHg) or mild hypoxemia (60 mmHg < P(a)O(2) < 80 mmHg) groups; (2) massive and non-massive PE; (3) absence or presence of pre-existing cardiopulmonary disease; and (4) absence or presence of right ventricle dysfunction. Serum levels of liver enzymes were compared between groups.
Results:
Transaminase levels were higher in severe hypoxemia patients compared mild hypoxemia patients (p=0.045 and p=0.036). Albumin and bilirubin levels were lower and higher, respectively, in patients with severe and moderate hypoxemia compared to mild hypoxemia patients (p < 0.05 and p < 0.01). There was a negative correlation between hepatic markers and P(a)O(2) and %S(a)O(2): r=-0.212, p=0.032 between AST and %S(a)O(2); r=-0.243, p=0.013 and r=-0.241, p=0.014 between ALT and P(a)O(2) and %S(a)O(2); and r=-0.224, p=0.024 and r= -0.283, p=0.004 between direct bilirubin and P(a)O(2) and %S(a)O(2). AST and ALT levels were higher in massive PE than non-massive PE patients (p=0.0001). Albumin levels were lower in patients with right ventricle dysfunction than in those without (p=0.02). One (0.9%) had a clinical picture of hypoxic hepatitis.
Conclusion:
Abnormal LFTs showed a mixed pattern in patients with acute PE.
Related Concept Videos
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
